Search results
Results From The WOW.Com Content Network
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman , Jordan in 1978.
Teva's generic launch comes days after the U.S. Food and Drug Administration tentatively approved London-based Hikma Pharmaceuticals' generic version of Victoza, according to the agency's website.
Baxter acquired medical device firm Baxa on November 10, 2011. [18] In 2011, Hikma Pharmaceuticals PLC completed the acquisition of Baxter Healthcare Corporation's US generic injectables business (Multi-Source Injectables or MSI). [19] [20] In July 2013, EU antitrust regulators approved Baxter's bid for Sweden's Gambro. [21]
BTG Limited is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changed its name on 27 May 1998. [2]
BOSTON (Reuters) -A division of French advertising company Publicis Groupe SA and drug company Hikma Pharmaceuticals have reached separate settlements worth a collective $500 million to resolve ...
Liraglutide was approved for medical use in the European Union in 2009, [4] and in the United States in 2010. [11] It is available as a generic medication. [12] In 2022, it was the 139th most commonly prescribed medication in the United States, with more than 4 million prescriptions. [13] [14]
The Electronic Medicines Compendium is a provider of information on medicines, produced by Datapharm. It lists summaries of product characteristics and patient information leaflets . [ 1 ] [ 2 ]
The MHRA has several independent advisory committees which provide the UK Government with information and guidance on the regulation of medicines and medical devices. There are currently eight such committees: [citation needed] Advisory Board on the Registration of Homeopathic Products; Herbal Medicines Advisory Committee; The Review Panel